Bio-Connect

Goat anti-ADRB1 Antibody

EB07133
Everest Biotech
ApplicationsImmunoFluorescence, ELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityCanine, Human, Mouse, Rat
TargetADRB1
100 ug
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Everest Biotech
  • Product Name
    Goat anti-ADRB1 Antibody
  • Delivery Days Customer
    5
  • Application Supplier Note
    Immunofluorescence: Strong expression of the protein seen in the plama membrane and cytoplasm of HeLa cells. Recommended concentration: 10microg/ml.
  • Applications
    ImmunoFluorescence, ELISA, ImmunoHistoChemistry
  • Applications Supplier
    Pep-ELISA, IHC, IF
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.5 mg/ml
  • Gene ID153
  • Target name
    ADRB1
  • Target description
    adrenoceptor beta 1
  • Target synonyms
    ADRB1R, B1AR, BETA1AR, FNSS2, RHR, beta-1 adrenergic receptor, adrenergic, beta-1-, receptor, beta-1 adrenoceptor, beta-1 adrenoreceptor
  • Host
    Goat
  • Scientific Description
    RefSeq number(s): NP_000675.1. Purification: Antigen affinity purified. Names and symbols: ADRB1; adrenergic, beta-1-, receptor; ADRB1R; B1AR; BETA1AR; RHR; beta-1-adrenergic receptor
  • Reactivity
    Canine, Human, Mouse, Rat
  • Reactivity Supplier
    Human, Mouse, Rat, Dog
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Wallukat G, Prüss H, Müller J, et al. Functional autoantibodies in patients with different forms of dementia. PLoS One. 2018,13(3):e0192778. doi: 10.1371/journal.pone.0192778
    Read this paper
  • Wenzel K, Schulze-Rothe S, Müller J, et al. Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology. PLoS One. 2018,13(2):e0192615. doi: 10.1371/journal.pone.0192615
    Read this paper
  • Wenzel K, Schulze-Rothe S, Haberland A, et al. Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy. Heliyon. 2017,3(7):e00362. doi: 10.1016/j.heliyon.2017.e00362
    Read this paper
  • Wallukat G, Haberland A, Berg S, et al. The first aptamer-apheresis column specifically for clearing blood of β1-receptor autoantibodies. Circ J. 2012,76(10):2449-55.
    Read this paper
  • Haberland A, Wallukat G, Dahmen C, et al. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies. Circ Res. 2011,109(9):986-92. doi: 10.1161/CIRCRESAHA.111.253849
    Read this paper
  • Wallukat G, Muñoz Saravia SG, Haberland A, et al. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients. J Am Coll Cardiol. 2010,55(5):463-8. doi: 10.1016/j.jacc.2009.06.064
    Read this paper